Huaqiang Zhu

机构：Zhejiang Pharmaceutical College · ORCID：0000-0001-5275-2106

发表论文 103 篇 · 总被引 2043 次 · h-index 27

代表论文

• Preparation of Al-5Li@FSG powders through fluorination-energetic modification to improve the comprehensive performance of alloy powders (2025 · Chemical Engineering Journal · 被引 26)
• Circulating tumor cell-derived exosome–transmitted long non-coding RNA TTN-AS1 can promote the proliferation and migration of cholangiocarcinoma cells (2024 · Journal of Nanobiotechnology · 被引 19)
• A first-in-human phase I/II study of GFH375, a highly selective and potent oral KRAS G12D inhibitor in patients with KRAS G12D mutant advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 14)
• Tetrastigma hemsleyanum suppresses neuroinflammation in febrile seizures rats via regulating PKC-δ/caspase-1 signaling pathway (2023 · Journal of Ethnopharmacology · 被引 14)
• Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score–matched study of postoperative liver decompensation (2023 · European Radiology · 被引 12)
• Association between gut microbiota and hepatocellular carcinoma and biliary tract cancer: A mendelian randomization study (2024 · World Journal of Clinical Cases · 被引 10)